 Ocular Hypertension
"Ocular Hypertension" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A condition in which the intraocular pressure is elevated above normal and which may lead to glaucoma.
| Descriptor ID |
D009798
|
| MeSH Number(s) |
C11.525
|
| Concept/Terms |
Ocular Hypertension- Ocular Hypertension
- Hypertension, Ocular
- Hypertensions, Ocular
- Ocular Hypertensions
Glaucoma, Suspect- Glaucoma, Suspect
- Glaucomas, Suspect
- Suspect Glaucoma
- Suspect Glaucomas
|
Below are MeSH descriptors whose meaning is more general than "Ocular Hypertension".
Below are MeSH descriptors whose meaning is more specific than "Ocular Hypertension".
This graph shows the total number of publications written about "Ocular Hypertension" by people in UAMS Profiles by year, and whether "Ocular Hypertension" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2016 | 1 | 0 | 1 | | 2009 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Ocular Hypertension" by people in Profiles over the past ten years.
-
Weinreb RN, Bacharach J, Brubaker JW, Medeiros FA, Bejanian M, Bernstein P, Robinson MR. Bimatoprost Implant Biodegradation in the Phase 3, Randomized, 20-Month ARTEMIS Studies. J Ocul Pharmacol Ther. 2023 Jan-Feb; 39(1):55-62.
-
Naithani R, Jammal AA, Estrela T, Onyekaba NE, Medeiros FA. Association of an Objective Structural and Functional Reference Standard for Glaucoma with Quality of Life Outcomes. Ophthalmol Glaucoma. 2023 Mar-Apr; 6(2):160-168.
-
Kang JM, Jammal AA, Medeiros FA. Association between statin use and rates of structural and functional loss in glaucoma. Br J Ophthalmol. 2023 09; 107(9):1269-1274.
-
Jammal AA, Berchuck SI, Mariottoni EB, Tanna AP, Costa VP, Medeiros FA. Blood Pressure and Glaucomatous Progression in a Large Clinical Population. Ophthalmology. 2022 02; 129(2):161-170.
-
Reina-Torres E, Wen JC, Liu KC, Li G, Sherwood JM, Chang JY, Challa P, Fl?gel-Koch CM, Stamer WD, Allingham RR, Overby DR. VEGF as a Paracrine Regulator of Conventional Outflow Facility. Invest Ophthalmol Vis Sci. 2017 03 01; 58(3):1899-1908.
-
Theodoropoulou S, Ellabban AA, Johnston RL, Cilliers H, Mohamed Q, Sallam AB. Short-term safety of dexamethasone implant for treatment of macular edema due to retinal vein occlusion, in eyes with glaucoma or treated ocular hypertension. Graefes Arch Clin Exp Ophthalmol. 2017 Apr; 255(4):725-732.
-
Morshedi RG, Ricca AM, Wirostko BM. Ocular Hypertension Following Intravitreal Antivascular Endothelial Growth Factor Therapy: Review of the Literature and Possible Role of Nitric Oxide. J Glaucoma. 2016 Mar; 25(3):291-300.
-
Ricca AM, Morshedi RG, Wirostko BM. High intraocular pressure following anti-vascular endothelial growth factor therapy: proposed pathophysiology due to altered nitric oxide metabolism. J Ocul Pharmacol Ther. 2015 Feb; 31(1):2-10.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|